Range
12.35 - 13.91
Vol / Avg.
33.9K/84.5K
Div / Yield
-
52 Wk
11.12 - 29.46
Mkt Cap
310M
Payout Ratio
-
Open
13.1
P/E
-
EPS
-0.53
Shares
23.7M
Outstanding
23.7M
Total Float
16.5M
Sector: Health Care.Industry: Biotechnology
Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-11
REV
Q2 2021Est.ActualSurprise
EPS-0.570-0.530 0.0400
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
INZYInozyme Pharma-1.95%310M

Inozyme Pharma Questions & Anwsers

Q

How do I buy Inozyme Pharma (INZY) stock?

A

You can purchase shares of Inozyme Pharma (NASDAQ: INZY) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Inozyme Pharma's (INZY) competitors?

Q

What is the target price for Inozyme Pharma (INZY) stock?

A

The latest price target for Inozyme Pharma (NASDAQ: INZY) was reported by Wedbush on August 18, 2020. The analyst firm set a price target for 35.00 expecting INZY to rise to within 12 months (a possible 167.18% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Inozyme Pharma (INZY)?

A

The stock price for Inozyme Pharma (NASDAQ: INZY) is $13.1 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Inozyme Pharma (INZY) pay a dividend?

A

There are no upcoming dividends for Inozyme Pharma.

Q

When is Inozyme Pharma (NASDAQ:INZY) reporting earnings?

A
Inozyme Pharma’s Q3 earnings are confirmed for after-market on November 11, 2021.
Q

Is Inozyme Pharma (INZY) going to split?

A

There is no upcoming split for Inozyme Pharma.

Q

What sector and industry does Inozyme Pharma (INZY) operate in?

A

Inozyme Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.